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.\bstract Glutamate evoked pertussis toxin-sensitive currents in 
.Yenopus oocytes expressing metabotropic glutamate receptor 
subtype 1 (mGluR1) and exogenous Gila. The mGluRl-currents 
were completely blocked by U-73122, a phospholipase C (PLC) 
inhibitor and by niflumic acid, a chloride channel blocker. In the 
crocyte further coinjected with poly(A)+ RNA from the guinea pig 
cerebellum, the mGluRl-currents were inhibited by U-50488H, 
an opioid K-agonist, and this inhibition was blocked by norbinal- 
torphimine, an opioid K-antagonist. These findings suggest that 
the mRNA encoding a novel subtype of opioid K-receptor which 
inhibits Gil-PLC-mediated currents is present in guinea pig cer- 
tbellar poly(A)+ fractions. 
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i . Introduction 
Until now it has been generally believed that guanine nucle- 
j btide-binding protein (G-protein)-coupled receptors, including 
c hpioid receptors, always transduce ‘stimulatory’ signals to G- 
1 broteins [1,2]. Recently, 6-, ,u- and rc-subtype opioid receptors 
kave been cloned [3-51, and we have demonstrated that these 
I eceptors mediate phospholipase C (PLC) activation through 
. stimulation of Gil in Xenopus oocytes [6-91. From experi- 
111ents using reconstitution techniques, however, it was found 
I hat in guinea pig cerebellar membranes Fc-opioid receptor ag- 
j Nnists transduce ‘inhibitory’ signals to Gil (or Gi2), but not Go 
f I O&12], thereby inhibiting PLC [13,14]. It was speculated in 
j uch reports that some populations of opioid #-receptors might 
ile coupled to Gil in an inverse (or inhibitory) manner. Here 
Je report the evidence for the presence of mRNA encoding 
. uch a novel type of opioid x-receptor, by use of the Xrnopus 
locyte expression system. 
. . Materials and methods 
.I. Xenopus oocyte experiments 
Details of treatment of Xenopus laevis for defolliculation, RNA injec- 
on and electrophysiological recording were described previously [&Y]. 
; :NAs except for poly(A)’ RNA to be injected into oocytes were gener- 
ted by in vitro transcription, primed with cap dinucleotide 
1’G(S’)ppp(5’)G using Stratagene kit from each cDNA clone. For the 
) ejection into oocytes, 100 ng of poly(A)‘, 10 ng of metabotropic gluta- 
! late receptor type 1 (mGluR1) RNA and 50 ng of Gila-subunit RNA 
151 were used. After further 3 days incubation at 19°C to allow for 
i protein expression, responses to bath application or intracellular injec- 
f on of test drugs were detected in injected Xenopus oocytes using 
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voltage-clamp recording. The holding potential was -60 mV and the 
current signals were low-pass-filtered at 5-10 Hz. In standard experi- 
ments. glutamate (60 PM or 1 mM) was applied to the bath for 1 min 
every 15 min unless otherwise stated. Test drugs were applied for 14 min 
from 7 min prior to the following glutamate challenge. unless otherwise 
stated. 
2.2. Preuctiaution of pertussis toxin 
Pertussis toxin (PTX, 50 pg) was dissolved in 20 ~1 of high K’ buffer 
(96 mM KCl, 2 mM NaCI, 1 mM MgCl?, 5 mM HEPES, pH 7.5). 
containing 40 mM DTT and 3 mM ATP, and incubated for 20 min at 
37°C. The activated PTX was diluted to a concentration of 0.25 ng/nl 
of high K’ buffer, containing 10 mM NAD, and used for intracellular 
injection (20 nl). Vehicle-control without PTX was prepared. as men- 
tioned above. 
2.3. Immunochemical detection of exogenously rqve.ssed Gila ond 
naturally e?cpressed Gqa in oocytes injected with Gila RNA 
In order to confirm the expression of exogenous Gila, oocytes (40 
eggs) which had been injected with Gila RNA (50 ng) per oocyte were 
sonicated in 800@ of homogenization buffer (20 mM Tris-HCl, 10 mM 
EGTA, 2 mM EDTA. 250 mM sucrose, 50 ,LLM p-(amidino- 
phenyl)methanesulfonyl fluoride and 20 pg/ml leupeptin) and centri- 
fuged I.000 x g for 10 min at 4°C. Aliquots of supernatant membrane 
preparations (equivalent to 10 eggs) were subjected to PTX-catalyzed 
ADP-ribosylation by the method of Katada and Ui 1161. Briefly, the 
membranes (50 pg protein) were incubated in 100 ,LLI of reaction buffer 
(100 mM Tris-HCI. 10 mM thvmidine. I mM EDTA. 1 mM DTT. 2.5 
iM [“PINAD (30.000 cpm/pmol) and I pug of preactivated PTX) at 
30°C for 60 min. The reaction was terminated by the addition of 10~1 
of trichloroacetic acid (TCA), and the precipitates were heated at 95°C 
for 3 min in 25 ul of 10 mM Tris-HCl (DH 7.5) containing 0.2 mM DTT 
and 2% SDS, ahded with 10~1 of 10 n&l N-ethylmaleim;e (NEM) and 
kept at room temperature for 15 min. The sample was mixed with 10 
~1 of 4x SDS-sample buffer (250 mM Tris-HCI. 400 mM DTT, 8% 
SDS, 40% glycerol, pH 6.8) and analyzed on 12% polyacrylamide SDS- 
PAGE [ 171. For immunoprecipitation. commercially available Gil a 
antiserum (DuPont-NEN. AS/7), which is specdic for Gta, Gila and 
Gi2a. was used. In such experiments ADP-ribosylation reaction (100 
~1) was terminated by adding I pl of 10% SDS, followed by heating at 
95°C for 5 min. The preparation was then mixed with 100~1 of precip- 
itation buffer (100 mM NaPO,. 300 mM NaCl, 4 mM EDTA. 4 mM 
DTT, 1% SDS, 2% sodium deoxycholate and 2% Triton X-100. pH 7.2). 
and kept on ice for 15 min. To reduce the background activity, normal 
goat serum (I : 100) was added to the preparation and they were further 
kept on ice for 15 min, followed by incubation with protein G-Sepha- 
rose 4FF (40 ~1 of 50% slurry in 0.4% bovine serum albumin) for 120 
min. The mixture was centrifuged at 3,000 x g for 3 min. and the 
supernatant was mixed with 5 ~1 of Gila antiserum. The samples were 
incubated at 4°C overnight, followed by incubation with protein G- 
Sepharose 4FF and centrifugation. as above-mentioned. After the 
Sepharose pellet was washed three times with 50 mM NaPO,. 150 mM 
NaCI, I mM EDTA and 0.5% Triton X-100, pH 7.2, the sample was 
heated in 2% SDS and 0.2 mM DTT. and treated with NEM, as 
mentioned above. The suspension was further added with 10 ~1 of 4x 
SDS-sample buffer. heated at 95°C for 5 min and added with IO pg of 
bovine serum albumin as a carrier. The [i’P]ADP-ribosylated materials 
were then precipitated by TCA, and analyzed by SDS-PAGE, as men- 
tioned above. Autoradiography was achieved by exposure of dried 
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polyacrylamide gel to Hyperfilm MP (Amersham) at -80°C with Du- 
pont Cronex Lightning Plus intensifying screens. SeeBlue (Novex) 
stained markers were used as molecular standards. 
For the determination of Gqtl, oocyte membrane preparations, as 
prepared above (equivalent to 30 eggs) were diluted with 3-volumes of 
TED buffer (20 mM Tris-HCI, 1 mM EDTA, 10 mM DTT, pH 7.5) 
containing aprotinin (25 kallikrein u/ml) and centrifuged at 15,000 
rpm x 20 min. The membrane pellets were then resuspended in 100 ~1 
of TED/aprotinin containing 100 mM NaCl and 0.1% sodium cholate, 
and spun down. The pellets were resuspended in 10 ~1 of TED/aprot- 
inin, added by 10~1 of 2% sodium cholate without agitation and placed 
on ice for 1 h. The samples were centrifuged at 15,000 rpm x 30 min 
and supernatants were carefully removed and applied on 12% 
acrylamide SDS-PAGE. Proteins were transferred to PVDF mem- 
branes (Millipore) and probed with anti-Gq antibody. The antibodies 
bound to the membrane were detected by horseradish peroxidase con- 
jugated goat anti-rabbit IgG (KPL) and the chromogenic substrate 
4-chloro-l-naphtol (Sigma). 
2.4. Chemicals 
U-50488H was a gift from Upjohn Japan (Tokyo), norbinaltorphim- 
ine (Nor-BNI) from Dr. H. Nagase (Toray, Japan) and other reagents 
from Sigma. 
3. Results 
3.1. Partial sensitivity of glutamate-currents to PTX in oocytes 
injected with mGluR1 receptor RNA 
In oocytes injected with mGluR1 RNA, the challenge of 1 
mM glutamate evoked sharp inward currents at the holding 
potential of -60 mV (Fig. lA), as many other investigators 
reported [l&19]. Average (&S.E.M.) of glutamate-currents 
(mGluRl-currents) upon the first challenge was 960 f 80 nA 
PTX 
A 
Glu 1 mM 
t 
//--I 
20min - - - - - 
-Ti* Y’ 
Glu 1 mM 
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(n = 8). Repeated challenges of glutamate at 15 min intervals 
lead to a slow desensitization and showed plateau responses at 
approximately 60 min after the initial challenge (Fig. 1A). The 
mGluRl-currents upon the fourth challenge was 360 +_ 180 nA 
(n = 8). However, there was no significant currents evoked by 
glutamate in oocytes not injected with mGluR1 RNA (data not 
shown). 
When 5 ng of pertussis toxin which had been preactivated 
was injected together with 10 mM NAD into the oocyte in a 
volume of 20 nl, mGluRl-currents were partially attenuated 
(Fig. 1A). However, the vehicle injection with NAD had no 
significant change in mGluRl-currents, as shown in Fig. 1B. 
From the replicated experiments it was revealed that the aver- 
age of mGluRl-currents 20 min after PTX-injection was 
49.1 ? 17.9% (n = 3) of the currents just before the injection, 
which is statistically different (ANOVA) from that of non- 
treated control (99.8 ? 10.6%, n = 3) or of vehicle control 
(95.5 f 13.2%, IZ = 6), as shown in Fig. 1C. 
3.2. Characterization of PTX-sensitive mGluRI-currents in 
oocytes injected with mGluR1 receptor and Gila RNAs 
When Gila RNA was coinjected together with mGluR1 
RNA, the mGluRl-currents upon the first challenge were 
markedly reduced (290 + 51 nA, n = 8), compared with the case 
without Gila RNA, as shown in Fig. 2A. However, the atten- 
uation of evoked currents upon repeated challenges was less 
evident than the latter case. The average of mGluRl-currents 
upon the fourth challenge was 180 t 29 nA (n = 8). In oocytes 
coinjected with Gila RNA, the mGluRl-currents were accom- 
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Fig. 1. Partial sensitivity of mGluRl-currents to pertussis toxin (PTX) in oocytes not coinjected with Gila RNA. (A) Effects of PTX-injection on 
mGluRl-currents. Preactivated PTX (5 ng) was injected with 10 mM NAD in a volume of 20 nl of high-K’ solution into oocytes, 10 min after the 
fourth challenge of glutamate. The following glutamate-challenge was performed 20 min after the PTX-injection, as indicated in the figure. (B) Effects 
of vehicle-injection on mGluRl-currents. Vehicle containing 10 mM NAD was injected as described in A. (C) Statistical comparison of effects of 
PTX-injection on mGluRl-currents with non-injection or with vehicle-injection. Results represent the ratio of mGluRl-currents 30 min after the 
fourth challenge (Control), 20 min after PTX-injection (PTX) and 20 min after vehicle-injection (Vehicle) to those upon the fourth challenge. 
*P < 0.05, compared with Control or Vehicle (ANOVA). 
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‘ig. 2. PTX-sensitive mGluRl-currents through Gil and PLC in oocytes injected with Gila RNA. (A and B) Effects of PTX- (A) or vehicle-injection 
1 B) on mGluRl-currents in oocytes coinjected with Gila RNA. Details are described in the legend of Fig. 1. (C-E) Effects of 1 PM U-73122 (C), 
PM U-73343 or 200pM niflumic acid (NFA) on repeated mGluRl-currents. Each drug was bath-applied for 14 min from 7 min prior to the following 
:lutamate-challenge. (F) Statistical comparison of effects of PTX-injection on mGluRl-currents with the non-injection or with the vehicle-injection. 
details are described in the legend of Fig. 1. (G) Statistical comparison of effects ofvarious drugs on mGluRl-currents. ** and *** P < 0.05, compared 
‘0 control without any drug (ANOVA). 
lanied by oscillating currents of relatively slow onset as well 
ts sharp currents of rapid onset. In some cases, no such rapid 
:omponents were observed. The injection of preactivated PTX 
5 ng) together with NAD completely abolished the mGluRl- 
.:urrents (Fig. 2A). However, the vehicle containing NAD alone 
\howed no significant change (Fig. 2B), as seen in the case with 
tjocytes not injected with Gila RNA (Fig. 1B). 
To characterize the PTX-sensitive mGluRl-currents, several 
pharmacological tools were used. The bath-application of U- 
73122, a specific inhibitor of PLC, completely blocked the 
mGluRl-currents in Gila RNA-injected oocytes (Fig. 2C). 
However, U-73343, an inactive derivative, showed no signifi- 
cant change (Fig. 2D). Similarly the bath-application of nif- 
lumic acid, a chloride channel blocker, abolished the mGluRl- 
currents (Fig. 2E). Several replicated experiments confirmed 
such results, as shown in Fig. 2F. 
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3.3. E.xpression of exogenous Gila in oocytes 
To detect exogenously expressed Gila, the oocyte mem- 
branes prepared at various time periods after its RNA injection 
were [‘*P]ADP-ribosylated by PTX. As shown in Fig. 3A, the 
radioactivity of [32P]ADP-ribosylated materials in preparations 
without Gila RNA was found only at 39 kDa on SDS-PAGE. 
However, the signal at 41 kDa was growing in preparations 
injected with Gila RNA, as the time of incubation. Marked 
increases were found at 72 and 84 h after the injection of the 
RNA. To identify the expressed G-protein, [32P]ADP-ribosyl- 
ated materials at 72 h were incubated with an antibody recog- 
nizing Gi 1 a, Gi2a and Gta, but not Gqa, Goa, Gi3a nor Gsa 
for immunoprecipitation. As shown in Fig. 3B, there was a 
significant signal at 41 kDa in preparations injected with Gi 1 a 
RNA, but not in preparations without it. In Western-blot ex- 
periments using an antibody recognizing Gqa and Gl la, on the 
contrary, there was a significant signal at 42 kDa, correspond- 
ing to Gqa [20] in preparations not injected with Gila RNA, 
while such a signal was markedly reduced in the same prepara- 
tions at 72 h after Gila RNA injection, as used in immunopre- 
cipitation experiments, 
3.4. Inhibition of PTX-sensitive mGluRl-currents by opioid K- 
ugonist in oocytes injected with mGluR1 and Gila and 
poly( A)’ RNAs from the guinea pig cerebellum 
In oocytes injected with mGluR1 and Gila and poly(A)’ 
RNAs, glutamate (60 ,uM or 1 mM) evoked inward currents of 
approximately 100 nA which are equivalent to the currents in 
oocytes without poly(A)’ RNA (Fig. 4A and B). In separate 
experiments such currents were also abolished by PTX-injec- 
tion. When 0.1 ,uM U-50488H, an opioid K-agonist was bath- 
applied 7 min prior to the following glutamate (60 PM)-chal- 
lenge to the oocyte, the mGluR 1 -currents were not affected, as 
shown in Fig. 4A. However, this opioid K-agonist at a higher 
A ADP-ribosylation 
- ““+ 
72 
?O+ - + 
84 (hr) 
- -b GilaRNA 
B Gil; Immunoprecipitation C Gq; Western blotting 
+4lkDa 
- + GilaRNA - + GilaRNA 
Fig. 3. Gila and Gqa expression in membranes of oocytes injected with 
Gila RNA. (A) Time course of [“PIADP-ribosylation of membrane 
G-proteins of oocytes injected with Gila RNA. Membranes were pre- 
pared from non-injected oocytes (-) or from injected ones (+) at 48,60, 
72 or 84 h after the injection. The membranes (50 pg) were incubated 
with [s*P]NAD and preactivated PTX, and subjected to analysis by 
SDS-PAGE, followed by autoradiography. (B) Immunoprecipitation 
of [“P]ADP-ribosylated materials using anti-Gila antiserum. Mem- 
branes (50 fig) at 72 h after the Gila RNA-injection were solubilized 
with detergent, immunoprecipitated, using anti-Gila antiserum, SDS- 
PAGE and autoradiographed. (C) Western-blot of Gqa. Membranes 
(100 pg), as used in B were solubilized and used for Western-blot 
experiments combined with visualization with horseradish peroxidase 
and 4-chloro-1-naphtol. 
U-50466H 0.1 KM U-50466H 1 A -- PM 
B 
L-Glu 1 mM 
’ I 1 25nA 
U-50466H 1kM 
Nor-BNI 50 nM Zmin. 
Fig. 4. Opioid rc-agonist-induced inhibition of mGluRl-currents in 
oocytes injected with mGluR1 RNA, Gila RNA and poly(A)’ RNA 
from the guinea pig cerebellum. (A) Representative data of opioid 
K-agonist-induced inhibition of mGluRl-currents. Glutamate at 60 uM 
wasused in this experiment. U-50488H (0.1 ,uM or 1 ,LLM) was bath- 
applied for 14 min from 7 min prior to the glutamate challenge. 
(B) Another representative result of U-50488H-induced inhibition of 
mGluR1 (1 mM)-currents and antagonism by nor-binaltorphimine 
(Nor-BNI). Test drugs were given as indicated in the figure. 
concentration (1 PM) markedly inhibited the mGluRl-cur- 
rents, and a complete recovery was observed at the second 
challenge after the washout of U-50488H. In a separate oocyte 
injected similarly, U-50488H at 1 PM also abolished the 
mGluRl-currents by 1 mM glutamate, and such inhibitory 
effects were completely blocked by 50 nM Nor-BNI, a selective 
opioid K-antagonist (Fig. 4B). After the cease of Nor-BNI- 
application, the U-50488H-induced inhibition of mGluRl-cur- 
rents was observed again. The mGluRl-currents were recov- 
ered after the wash of these opioid compounds, though there 
was a small attenuation. However, there was no inhibition of 
Gil-mediated mGluRl-currents by U-50488H in oocytes not 
injected with poly(A)’ RNA (data not shown). Furthermore we 
have obtained similar results that muscarinic M2-receptor-cur- 
rents through Gil were also inhibited by this K-agonist in 
oocytes injected with poly(A)+ RNA (Ueda et al., unpublished 
data). 
4. Discussion 
Since we firstly reported that opioid K-agonists inhibit the 
high-affinity GTPase in guinea pig cerebellar membranes [lo], 
several investigators including ourselves have demonstrated the 
findings related to such a receptor-mediated inhibition of 
GTPase activity [21,22]. We have proposed the mechanisms of 
such inhibitory actions of opioid K-agonist through a receptor- 
mediated direct inhibition of GDP-GTP exchange activity (or 
intrinsic Gil-protein activity) from biochemical reconstitution 
experiments [ 11,121. 
The major finding in this report is that Gil-mediated 
mGluRl-currents were markedly attenuated by U-50488H, a 
specific opioid K-agonist, and such an inhibition was reversed 
by Nor-BNI, a specific opioid K-receptor antagonist. As there 
was no inhibition of Gil-mediated mGluRl-currents by U- 
50488H in oocytes not injected with poly(A)’ RNA, it is sug- 
gested that a certain opioid receptor of n-subtype is involved 
in the inhibition of Gil-mediated currents. 
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In the present study we used the cross-talk mechanism with 
metabotropic glutamate receptor, mGluR1 at the level of Gil 
I~, detect the inhibition of intrinsic G-protein activity. Although 
mGluRl-currents were reported to be in part sensitive to PTX 
[ 181, it has been considered that such currents are mediated 
trough Gqa-PLC mechanisms [19], since PLC is predomi- 
I antly regulated by Gq [23]. On the other hand, we have re- 
1 orted that Gil also plays important roles in such a PLC- 
; ctivation in biochemical studies in which we adopted the re- 
t onstitution experiments using purified Gil [14,24]. In our cur- 
1 -nt experiments, we have shown that 6-, p- and rc-opioid recep- 
I )rs evoked calcium-dependent chloride currents through an 
; ctivation of PLC in oocytes reconstituted with exogenously 
L xpressed Gi I a [6-91. In such studies, 6-opioid receptor which 
I ; known to couple to Gil, Gi2, Gi3 and Go in some other cells 
: howed enhanced currents in oocytes when injected with RNA 
c f Gila or Gi2a, but not of Gi3a nor Gocl [9]. These findings 
: uggest that both Gil and Gi2 are more potent in an activation 
t ,f PLC than Gi3 or Go, and that their a-subunits are more 
: sotent than &-subunits, provided py-subunits are common to 
hese heterotrimeric G-proteins. Most recently the former view 
las confirmed by the report that recombinant Go in an active 
.3rrn failed to stimulate PLCB, purified from the brain, in 
sconstituted vesicles [25]. Thus, we attempted to detect PTX- 
ensitive mGluRl-currents by an overexpression of Gila. In- 
1 eed, the mGluR 1 -currents were completely abolished by PTX- 
ejection in oocytes injected with Gilcl RNA, but only partially 
I those without the RNA. Such a difference in the PTX- 
ensitivity might be explained by the view that exogenously 
j xpressed Gila absorbs common By-subunits from Gqc$y 
ieterotrimers, resulting in predominance of Gi I Orgy hetero- 
rimers in injected oocytes. This view was further supported by 
he present data that Gqcr-like immunoreactivities in oocyte 
nembranes were markedly decreased at the time when Gila 
t xpression maximally increased. This may suggest that Gqa 
nonomer dissociated from &-subunits under the condition of 
?ila overexpression is not tightly anchored to the membrane, 
ince isoprenylated y-subunit is very important for membrane 
nchoring of heterotrimeric G-proteins [26]. 
The Gi 1 -mediated mGluR 1 -currents were completely 
Ilocked by U-73 122, an aminosteroid-type PLC inhibitor, but 
lot by U-73343, an inactive derivative which differs by only a 
ingle double bond [27]. The bath-application of U-73122 itself 
howed no significant change in basal currents, suggesting that 
nGluR1 -currents were unlikely abolished by mechanisms sec- 
lndary to the inhibition of spontaneous PLC activity by U- 
‘3 122. The mGluR l-currents were also completely blocked by 
liflumic acid, a chloride channel blocker which is well known 
o block calcium-dependent chloride channels naturally ex- 
jressed in Xenopus oocytes [28]. These findings are consistent 
vith the data in our previous reports that Gil- and PLC- 
nediated currents are through calcium-dependent chloride 
hannels [6-91. 
This report is consistent with our previous and current find- 
ngs that the opioid K-agonists inhibits the PLC activity stimu- 
dted by GTP through Gil reconstituted into PTX-treated 
nembranes and provides the evidence for the presence of 
205 
opioid K-receptor inhibiting PLC activity through Gil. As 
cloned opioid K-receptor evokes chloride currents through an 
activation of Gil and PLC in the oocyte [8], the present Gil- 
inhibitory, or ‘metabostatic’ receptor activity is likely through 
a new receptor different from such a known Fc-opioid receptor. 
However, details must await the expression cloning of this 
receptor which is now in progress in our laboratory. 
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